Basic Information
| LncRNA/CircRNA Name | RBMS3-AS3 |
| Synonyms | NA |
| Region | GRCh38_3:29264194-29290726 |
| Ensemble | ENSG00000235904 |
| Refseq | NR_109804 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | RT-qPCR, Western blot, RIP |
| Sample | prostate cancer tissues,cell lines |
| Expression Pattern | down-regulated |
| Function Description | overexpression of RBMS3-AS3 was found to suppress cell proliferation, migration, invasion, and angiogenesis as well as the tumorigenic ability of prostate cancer. |
| Pubmed ID | 31712637 |
| Year | 2019 |
| Title | Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1 |
External Links
| Links for RBMS3-AS3 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |